English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Insan bagisiklik yetmezlik virusu ile enfekte hastalarda kronik hepatit B virusu (HBV) ve hepatit C virusu (HCV) enfeksiyonlari da arastirilmalidir. Bu hastalarda kronik viral hepatitler daha hizli ilerler ve siroz daha cabuk gelisir. Tani konulduktan sonra kronik viral hepatitler icin etkin tedavi verilebilir. HBV’nin replikasyonunu tenofovir iceren anti-retroviral tedaviler ile baskilamak mumkundur. Dogrudan etkili antiviral ilaclarin gelistirilmesiyle HCV enfeksiyonunun sagaltimi mumkun hale gelmistir. Anahtar Kelimeler: Insan bagisiklik yetmezlik virusu, kronik hepatit B, kronik hepatit C, ko-enfeksiyon Infectious diseases physicians taking care of human immunodeficiency virus-infected patients should investigate for the presence of chronic hepatitis caused by hepatitis B and hepatitis C virus infections. This is important as chronic viral hepatitis progresses more rapidly to end-stage liver disease in human immunodeficiency virus-infected patients. Once diagnosed, there are effective drugs for the treatment chronic viral hepatitis. Tenofovir containing anti-retroviral therapy effectively suppresses hepatitis B replication. Hepatitis C cure can be achieved with directly acting antiviral agents.

Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients